The perfect personalized cancer therapy: cancer vaccines against neoantigens

In the advent of Immune Checkpoint inhibitors (ICI) and of CAR-T adoptive T-cells, the new frontier in Oncology is Cancer Immunotherapy because of its ability to provide long term clinical benefit in metastatic disease in several solid and liquid tumor types. It is now clear that ICI acts by unmaski...

Descripción completa

Detalles Bibliográficos
Autores principales: Aurisicchio, Luigi, Pallocca, Matteo, Ciliberto, Gennaro, Palombo, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910567/
https://www.ncbi.nlm.nih.gov/pubmed/29678194
http://dx.doi.org/10.1186/s13046-018-0751-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910567/
https://www.ncbi.nlm.nih.gov/pubmed/29678194
http://dx.doi.org/10.1186/s13046-018-0751-1

Ejemplares similares